Small interfering RNA for cancer treatment: overcoming hurdles in delivery

In many ways, cancer cells are different from healthy cells. A lot of tactical nano-based drug delivery systems are based on the difference between cancer and healthy cells. Currently, nanotechnology-based delivery systems are the most promising tool to deliver DNA-based products to cancer cells. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Charbe, Nitin Bharat, Amnerkar, Nikhil D., Ramesh, B., Tambuwala, Murtaza M., Bakshi, Hamid A., Aljabali, Alaa A.A., Khadse, Saurabh C., Satheeshkumar, Rajendran, Satija, Saurabh, Metha, Meenu, Chellappan, Dinesh Kumar, Shrivastava, Garima, Gupta, Gaurav, Negi, Poonam, Dua, Kamal, Zacconi, Flavia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714980/
https://www.ncbi.nlm.nih.gov/pubmed/33304780
http://dx.doi.org/10.1016/j.apsb.2020.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714980/
https://www.ncbi.nlm.nih.gov/pubmed/33304780
http://dx.doi.org/10.1016/j.apsb.2020.10.005

Ejemplares similares